Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
BCL-XL INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2023/185986
Kind Code:
A1
Abstract:
Disclosed herein is a compound of Formula (I) for inhibiting Bcl-xL and treating a disease associated with the undesirable Bcl-xL activity (Bcl-xL related diseases), a method of using the compounds disclosed herein for treating tumor or cancer, and a pharmaceutical composition comprising the same.

Inventors:
QIN LING (CN)
GUO YUNHANG (CN)
WANG ZHIWEI (CN)
Application Number:
PCT/CN2023/084978
Publication Date:
October 05, 2023
Filing Date:
March 30, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BEIGENE LTD (GB)
QIN LING (CN)
International Classes:
C07D401/14; A61K31/4985; A61K31/53; A61P35/00; C07D487/04
Domestic Patent References:
WO2015074081A12015-05-21
WO2015074064A22015-05-21
WO2020024916A12020-02-06
Foreign References:
US20160256448A12016-09-08
US20160256458A12016-09-08
Attorney, Agent or Firm:
WU , FENG & ZHANG (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: BIOMARKER, SYSTEM, METHOD, AND KIT FOR ASSESSING EFFICACY OF TUMOR IBC THERAPY

Next Patent: TRANSMISSION PROCESSING METHOD, NETWORK DEVICE, TERMINAL, APPARATUS AND STORAGE MEDIUM